Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Bio-Rad Laboratories, Inc. v. 10X Genomics, Inc.
Case Number:
1:18-cv-01679
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 08, 2019
Bio-Rad Cleared To Enforce Sample Protection Patents
Bio-Rad Laboratories Inc.'s technology to reduce sample contamination and loss is patent-eligible, a Delaware federal judge said Monday in allowing the company to press forward with an infringement suit against 10X Genomics Inc.
-
November 14, 2018
Bio-Rad Wins $24M Jury Verdict In 10X Genomics Patent Suit
A Delaware federal judge on Wednesday ordered 10X Genomics Inc. to pay nearly $24 million to Bio-Rad Laboratories Inc. and the University of Chicago after a jury found that it infringed a droplet-based method of manipulating DNA.